Trial Profile
A multicenter prospective cohort study evaluating the real-world safety and efficacy of sofosbuvir plus ribavirin in eldery patients over 75 years of age infected with genotype 2 hepatitis C virus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 May 2018
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 16 May 2018 New trial record
- 14 Apr 2018 Results presented at The International Liver Congress 2018